• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Iron Deficiency Anemia - Pipeline Review, H2 2011 - Product Image

Iron Deficiency Anemia - Pipeline Review, H2 2011

  • Published: August 2011
  • 42 pages
  • Global Markets Direct

Iron Deficiency Anemia - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Iron Deficiency Anemia - Pipeline Review, H2 2011', provides an overview of the Iron Deficiency Anemia therapeutic pipeline. This report provides information on the therapeutic development for Iron Deficiency Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia. 'Iron Deficiency Anemia - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Iron Deficiency Anemia.
- A review of the Iron Deficiency Anemia products under development by companies READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Iron Deficiency Anemia Overview
Therapeutics Development
An Overview of Pipeline Products for Iron Deficiency Anemia
Iron Deficiency Anemia Therapeutics under Development by Companies
Iron Deficiency Anemia Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Iron Deficiency Anemia Therapeutics - Products under Development by Companies
Iron Deficiency Anemia Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Iron Deficiency Anemia Therapeutics Development
Rockwell Medical Technologies, Inc.
Galenica Ltd.
3SBio Inc.
Iron Deficiency Anemia - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
SFP-Peritoneal Dialysis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SFP-Oral Prescription - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Feraheme - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SFP-Hemodialysis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ferinject - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proferrin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ST10-021 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Iron Deficiency Anemia Therapeutics – Drug Profile Updates
Iron Deficiency Anemia - Featured News
May 23, 2011: Pieris Announces Preclinical In Vitro And In Vivo Data For Anticalin PRS-080 Hepcidin Antagonist Drug Program
Apr 26, 2011: Rockwell Medical Begins Second Phase III Clinical Trial For Treatment Of Iron Deficiency In Dialysis Patients
Mar 24, 2011: Rockwell Medical Starts Pivotal Phase III Clinical Study For Treatment Of Iron Deficiency Anemia In Dialysis Patients
Feb 16, 2011: Rockwell Medical Commences PRIME Clinical Study
Feb 08, 2011: AMAG Pharmaceuticals Provides Update On Canadian New Drug Submission For Feraheme
Jan 25, 2011: Rockwell Medical Announces Dialysis Companies To Participate In SFP Phase III CRUISE Studies
Nov 29, 2010: AMAG Provides Update On Feraheme Label
Nov 01, 2010: Shield Signs Agreement For ST10-021 With AOP Orphan Pharmaceuticals
Oct 26, 2010: Rockwell Medical Receives Soluble Ferric Pyrophosphate Patent For GMP Formulation In US
Oct 20, 2010: Rockwell Medical Reports Design Of Phase III Iron Therapy Program For Soluble Ferric Pyrophosphate
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Iron Deficiency Anemia, H2 2011
Products under Development for Iron Deficiency Anemia – Comparative Analysis, H2 2011
Number of Products under Development by Companies, H2 2011
Number of Products under Investigation by Universities/Institutes, H2 2011
Comparative Analysis by Late Stage Development, H2 2011
Comparative Analysis by Pre-Clinical Stage Development, H2 2011
Products under Development by Companies, H2 2011
Products under Investigation by Universities/Institutes, H2 2011
Rockwell Medical Technologies, Inc., 2011
Galenica Ltd., 2011
3SBio Inc., 2011
Assessment by Monotherapy Products, H2 2011
Assessment by Stage and Route of Administration, H2 2011
Assessment by Molecule Type, H2 2011
Iron Deficiency Anemia Therapeutics – Drug Profile Updates

List of Figures
Number of Products under Development for Iron Deficiency Anemia, H2 2011
Products under Development for Iron Deficiency Anemia – Comparative Analysis, H2 2011
Products under Development by Companies, H2 2011
Products under Investigation by Universities/Institutes, H2 2011
Late Stage Products, H2 2011
Pre-Clinical Stage Products, H2 2011
Assessment by Monotherapy Products, H2 2011
Assessment by Route of Administration, H2 2011
Assessment by Stage and Route of Administration, H2 2011
Assessment by Molecule Type, H2 2011
Assessment by Stage and Molecule Type, H2 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos